The newer generation of HIV drugs have turned the once-lethal infection into a chronic condition, and cardiovascular disease has emerged as the leading cause of death in these individuals.
Sep 16, 2020
0
6
Two newer types of medications commonly used to treat type 2 diabetes are similar in their ability to reduce major heart complications, including heart attack, stroke and death from cardiovascular disease, according to research ...
Mar 31, 2020
0
0
Higher levels of the omega-3 fatty acid eicosapentaenoic acid (EPA) found in the blood—and not a decrease in triglyceride levels as originally thought—appear to explain the striking reductions in cardiovascular events ...
Mar 30, 2020
0
1
Nonsteroidal anti-inflammatory drugs (NSAIDs) can help to control the pain and inflammation in individuals with osteoarthritis (OA), but a new Arthritis & Rheumatology study suggests that NSAIDs contribute to cardiovascular ...
Aug 7, 2019
0
1
With hurricane season in full swing, the constant counsel along the nation's coastlines is to be prepared.
Aug 2, 2019
1
1
An analysis of published studies and reports indicates that a number of herbal products may affect the properties of prescription drugs, leading to alterations in the drugs' effectiveness as well as potentially dangerous ...
Jan 24, 2018
0
36
Genetic studies on Malaysia's Orang Asli peoples could lead to tailored medical advice that is more appropriate for their unique makeup.
May 1, 2017
0
1
The use of benzodiazepines and benzodiazepine-like drugs was associated with a 20 per cent increased risk of stroke among persons with Alzheimer's disease, shows a recent study from the University of Eastern Finland. Benzodiazepines ...
Jan 16, 2017
0
8
Saxagliptin (trade name: Onglyza) is approved for adults with type 2 diabetes mellitus whose blood-glucose levels are inadequately controlled by diet and exercise alone. The fixed combination with metformin is available under ...
Oct 11, 2016
0
0
In a study of 1000 adult patients with unplanned admission to a tertiary hospital in Singapore, the prevalence of adverse drug reactions (ADRs) at the time of admission was 12.4 percent, and the prevalence of ADRs causing ...
Sep 19, 2016
0
0
